Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.
Also called NCT05020535
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Registry
-
NCT05020535
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05020535. Randomized; quadruple masking; primary purpose treatment. Start 2022-10-10 (actual); primary completion 2026-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
- Acronym
- BEACH
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- MW189
- Intervention (Other)
- Saline
- Lead sponsor
- Johns Hopkins University
- Collaborator
- University of Kentucky
- Collaborator
- National Institute on Aging (NIA)
Record details
- Record id
cardio:ct-nct05020535- Content hash
6137e26532bacaa59444e8098ac7aed10f24903b4eb59f09d1fd82ff7ef7555c